Christopher Morgan

Director/Miembro de la Junta en

Alpha Cancer Technologies, Inc.

Commercial Services

Consumer Services

Electronic Technology

Perfil

Christopher W.
Morgan is currently Director at Alpha Cancer Technologies, Inc. Formerly, Mr. Morgan was Director at Spectra7 Microsystems, Inc. from 2021 to 2025 and Partner at Skadden, Arps, Slate, Meagher & Flom LLP.
Mr. Morgan earned an MBA from the University of Toronto.

Cargos activos de Christopher Morgan

Empresas	Cargo	Inicio
Alpha Cancer Technologies, Inc. Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs	Director/Miembro de la Junta	-

Todos los cargos activos de Christopher Morgan

Antiguos cargos conocidos de Christopher Morgan.

Empresas	Cargo	Fin
SPECTRA7 MICROSYSTEMS INC.	Director/Miembro de la Junta	28/04/2025
Skadden, Arps, Slate, Meagher & Flom LLP Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Christopher Morgan.

Formación de Christopher Morgan.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Christopher Morgan.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Skadden, Arps, Slate, Meagher & Flom LLP Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm	Commercial Services
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Spectra7 Microsystems, Inc. Spectra7 Microsystems, Inc. SemiconductorsElectronic Technology Manufactures semiconductor products	Electronic Technology
Alpha Cancer Technologies, Inc. Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs	Health Technology